Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01657500 · ClinicalTrials.gov registry record · Phase 3

Life 4°C Versus Optisol in Corneal Storage Media

A Phase 3 study, sponsored by University Hospitals Cleveland Medical Center.

Completed
Registry status
Phase 3
Development phase
64
Enrollment target

NCT01657500 is a Phase 3 study that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 64 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01657500, a Phase 3 study, has completed, sponsored by University Hospitals Cleveland Medical Center.

COMPLETED
Registry status
Phase 3
Development phase
64 participants
Enrollment target

Study Summary

The purpose of this study is to compare the success of storing a donor cornea in Optisol GS, the current standard vs. storing the donor cornea in Life4°C, a newer solution. The donor cornea to be used for EK will be provided by an eye bank and will have been stored in either an Optisol GS solution or a Life 4°C solution. At 6 months, the doctors will determine whether there are any comparable differences in cell loss and graft clarity between the two donor corneas.

Interventions

  • OTHER Corneal donor storage in Optisol GS media solution
  • OTHER Life 4°C solution for cornea storage

Trial Details

FieldValue
Enrollment Target 64 participants
Start Date 2011-06
Est. Completion 2012-10
Phase Phase 3

What the Registry Record Tells You About NCT01657500

The ClinicalTrials.gov registry entry for NCT01657500 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 64 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Corneal donor storage in Optisol GS media solution is the first listed.

NCT01657500 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01657500 about?

NCT01657500 is a clinical study titled "Life 4°C Versus Optisol in Corneal Storage Media". The purpose of this study is to compare the success of storing a donor cornea in Optisol GS, the current standard vs. storing the donor cornea in Life4°C, a newer solution. The donor cornea to be used for EK will be provided by an eye bank and will have been stored in either an Optisol GS solution o...

What is the current status of trial NCT01657500?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 64 participants. The study started on 2011-06. Estimated completion is 2012-10.

What interventions are being tested in trial NCT01657500?

The interventions under investigation include: Corneal donor storage in Optisol GS media solution (OTHER), Life 4°C solution for cornea storage (OTHER).

Who is sponsoring clinical trial NCT01657500?

This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.